Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir PK in Children with Chickenpox
NCT00169416Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2005
- Primary completion
- Aug 2005
- Modality
- Metabolically Activated Prodrugs
01
Overview
Phase 3, open-label, single-arm trial of valaciclovir in chickenpox, sponsored by GSK. Primary endpoint: Plasma aciclovir concentrations at 6 hours. Started Mar 2005; status: completed.
02
Drugs
valaciclovir
03
Conditions
chickenpox
Beyond the preview
Go deeper on NCT00169416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169416.